Therefore, it is essential to develop some novel adjunct non-insulin therapeutic strategies for maintaining glycemic control for the purpose of inducing weight loss and reducing the risk of CVD in adolescents with T1DM (8). This evidence concerns the gene INS and type 1 diabetes mellitus.